Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Early research targeting GLP-1 with oral glucose showed that it resulted in greater increases in insulin release and decreases in glucagon secretion compared with intravenous glucose
It is not authorised by the MHRA for human or veterinary use, and it is not a licensed medicine
& Elaissari, A
Other diabetes drugs that have faced significant price increases since coming to market include Eli Lillys Trulicity product, which has increased 91 percent since 2014, Eli Lilly and Boehringer Ingelheims Jardiance product, which has increased 97 percent since 2014, and Novo Nordisks Ozempic, which has increased 38 percent since just 2017
US$ 29.13
US$ 20.82
US$ 23.94
US$ 22.20
US$ 21.00
US$ 20.47
